Applied Biosciences

Applied BioSciences Corp. is a vertically integrated company, which focuses on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics or biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic area. The company is headquartered in Carson City, Nevada. The company went IPO on 2015-11-04. The firm operates in one segment for product and service distribution. The company sells consumer products including creams, tinctures, edibles, confections, clothing, apparel, and branded products. The company is involved in the bioceutical and pet health industries, distributing products to the U.S. states and various international markets. The company focuses on investments, consumer brands, and partnerships in the recreational, health and wellness, nutraceutical, and media industries. The company sources products from facilities in California, Colorado, Nevada, and Florida. The firm's brands include Remedi, Remedi Plus, HerbalPet, Champ Organics, and Equine Care. Its subsidiaries include Trace Analytics, Inc., VitaCBD LLC, API Holdings, and Applied Products LLC.